Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Stage D0 Androgen Dependent Prostate Cancer
NCT00004635Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2000
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in prostate cancer (PCa), sponsored by National Cancer Institute. Started Mar 2000; status: completed.
02
Drugs
thalidomide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00004635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004635.